It does. The thing is, it doesn't solve Ms. Foss's problem with their situation in terms of the structural discrepancies between continuing to have the drug tests and the [Technical difficulty—Editor] costs incurred in that, and the percentages that she can raise back to 1% from 0.8%. It doesn't change that, though.
On February 25th, 2021. See this statement in context.